Einrichtungen, die zum Universitätsklinikum Erlangen gehören

Renal hemangioblastoma and renal cell carcinoma with fibromyomatous stroma and hemangioblastoma-like areas belong to the spectrum of one entity (2025) Trpkov K, Salut N, Ribera-Cortada I, Xipell ET, Puigsureda IT, Yilmaz A, Husain AR, et al. Journal article AI for Automated vBMD and Fragility Assessment of the Proximal Femur in CT Scans KI zur automatisierten vBMD- und Fragilitätsanalyse des proximalen Femurs an CT-Scans (2025) Krekiehn NR, Bartenschlager S, Seidel R, Chaudry O, Sigurdsson S, Gudnason V, Hövener JB, et al. Journal article Segmenting Whole-Body MRI and CT for Multiorgan Anatomic Structure Delineation (2025) Häntze H, Xu L, Mertens CJ, Dorfner FJ, Donle L, Busch F, Kader A, et al. Journal article Simultaneous ultra-high resolution multi-energy cardiac imaging in a dual-source photon counting detector CT system (2025) Shanblatt E, Rajendran K, Swicklik JR, Allmendinger T, Schmidt B, Flohr T, McCollough CH, Leng S Journal article Gene Expression Profiling Provides an Improved Characterization of CD79B-Mutated Diffuse Large B-Cell Lymphomas (2025) Großmann L, Jagla W, Bettstetter M, Bertz S, Schwarz-Furlan S, Richter T, Dechow T, et al. Journal article Blood–Brain Barrier Dysfunction, Edema Formation and Functional Recovery in Ischemic and Hemorrhagic Stroke: A Retrospective Study (2025) Müller C, Sembill J, Kallmünzer B, Bailer M, Singer L, Engelhorn T, Dörfler A, et al. Journal article Phase II Clinical Study on Low-Intensity-Noise Tinnitus Suppression (LINTS) for Tinnitus Treatment (2025) Tziridis K, Heep L, Piwonski N, Nguyen K, Kölbl N, Schilling A, Schulze H Journal article Resolving Loss of Response to Ustekinumab in Crohn’s Disease: POWER Through or Switch Treatment? (2025) Noviello D, Atreya R, Noor NM Journal article Special Issue “Molecular Advances in Cancer Immunotherapy” (2025) Schaft N Journal article Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy (2025) Pfister K, Friedl TW, Hartkopf A, Mergel F, Huesmann S, Mehmeti F, Schäffler H, et al. Journal article